These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10448545)

  • 21. [The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial].
    Tfelt-Hansen P; Henry P; Mulder LJ; Scheldewaert RG; Schoenen J; Chazot G
    Ugeskr Laeger; 1996 Nov; 158(45):6435-9. PubMed ID: 8992678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial.
    Diener HC; Tfelt-Hansen P; de Beukelaar F; Ferrari MD; Olesen J; Dahlöf C; Mathew N;
    Cephalalgia; 2001 Jul; 21(6):672-9. PubMed ID: 11531899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.
    Derry CJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009665. PubMed ID: 22336869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
    Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.
    Sandrini G; Cerbo R; Del Bene E; Ferrari A; Genco S; Grazioli I; Martelletti P; Nappi G; Pinessi L; Sarchielli P; Tamburro P; Uslenghi C; Zanchin G
    Int J Clin Pract; 2007 Aug; 61(8):1256-69. PubMed ID: 17627707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Goldstein J; Smith TR; Pugach N; Griesser J; Sebree T; Pierce M
    Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study.
    Akpunonu BE; Mutgi AB; Federman DJ; Volinsky FG; Brickman K; Davis RL; Gilbert C; Asgharnejad M
    Ann Emerg Med; 1995 Apr; 25(4):464-9. PubMed ID: 7710149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
    Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
    Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP; Waymer RS
    Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
    Derry CJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.